BellBrook
Labs develops and manufactures detection reagents and microfluidic devices for the treatment of cancer and debilitating diseases... Read moreBellBrook
Labs develops and manufactures detection reagents and microfluidic devices for the treatment of cancer and debilitating diseases... Read more
News
Jan 14, 2019
EZPR
Press Release: BellBrook : BellBrook Labs Launches Transcreener cGAS Activity Assay to Accelerate Drug Discovery
Nov 11, 2018
BioPortfolio
BellBrook: BellBrook Labs LLC Medical Equipment Deals and Alliances Profile Report Updated 15102018 Prices from USD $250
Sep 06, 2018
BioPortfolio
BellBrook: BellBrook Labs to Exhibit New Applications for High Throughput Screening at the Discovery on Target Conference
Aug 30, 2018
PRWeb
Press Release: BellBrook : BellBrook Labs Publishes "A Guide to Measuring Drug-Target Residence Times with Biochemical Assays"
Aug 06, 2018
BioPortfolio
BellBrook: BellBrook Labs LLC Medical Equipment Deals and Alliances Profile Report Updated 18072018 Prices from USD $250
May 16, 2018
PRWeb
Press Release: BellBrook : NIH Awards BellBrook Labs Phase II Grant to Develop HTS Assays Targeting the cGAS-STING Pathway for Autoimmune Diseases and Cancer
Apr 06, 2018
SpaceGab
BellBrook: Streamline HTS and Lead Discovery with the Transcreener ADP Kinase Assay
Feb 14, 2018
BioPortfolio
BellBrook: BellBrook Labs LLC Medical Equipment Deals and Alliances Profile Report Updated 08022018 Prices from USD $250
Jan 31, 2018
SpaceGab
BellBrook: BellBrook Labs to Showcase New HTS Solutions for Methyltransferases and Cancer Immunotherapy Targets at the SLAS 2018 Conference
Aug 09, 2017
BioPortfolio
BellBrook: BellBrook Labs Launches UltraSensitive Methyltransferase Assay to Accelerate Epigenetic Drug Discovery
BellBrook Competitors
1
2
3
4
5
6
7
8
9
10